三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

UK firms' software helps in genome diagnosis

By ANGUS McNEICE | China Daily | Updated: 2017-05-09 17:52
Share
Share - WeChat

BGI Genomics, China's leading DNA sequencing provider, is partnering with United Kingdom genomics software company Congenica to bring cutting-edge genome-based medicine to China's healthcare system.

BGI has invested an undisclosed sum in Congenica, and signed commercial contracts to use the Cambridge-based company's software, called Sapientia, to support BGI operations in China. Sapientia analyzes a patient's entire genome, pinpointing mutations and generating rapid and accurate diagnosis of inherited diseases.

Li Ning, chief development officer at BGI, said the arrangement "offers multiple advantages" to BGI's healthcare partners in China.

Sapientia is used by Genomics England in the UK 100,000 Genomes Project, a Department of Health-backed plan to sequence genomes from National Health Service patients with rare diseases.

Professor Mark Caulfield, chief scientist at Genome England, told China Daily: "Genomics has the potential to transform healthcare, predicting how well a person will respond to a treatment or finding one that will work best for them."

Congenica CEO Tom Weaver said genome-based medicine will revolutionize healthcare, with some rare inherited diseases that previously would have taken years to diagnose now being diagnosed in days.

"Our software combines genetic information with clinical data and our algorithms and interpretation tools allow us to identify the likely mutations that are involved in that disease," Weaver said.

Currently, when a doctor suspects a patient has a certain inherited ailment, tests will be ordered on a small numbers of genes and an accurate diagnosis may be made in around 5 percent of cases.

"Now, imagine going in and looking at all 22,000 genes in a patient – you have a much higher chance of identifying the mutation and making a diagnosis," he said. "With this technology, we see an increase in an ability to diagnose a patient of at least 10 fold. We're seeing cases of up to 50-60 percent of diagnoses in certain conditions."

Congenica's entry into China offers its researchers access to a huge population in a country investing heavily in genomics. Along with a prolific level of DNA sequencing, China is moving forward with a precision-based medicine initiative, and researching how drugs affect different people in different ways by analyzing clinical data, health records and genetic information.

Last week, Yunfeng Capital, a fund backed by Jack Ma of Alibaba Group, invested $75 million in WuXi NextCODE, a contract genomics company headquartered in Shanghai.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 国产精品手机视频一区二区 | 亚洲1314 | 久久国产精品一区 | 精品美女在线观看 | 国产馆精品推荐在线观看 | 在线看欧美日韩中文字幕 | 日韩视频免费在线观看 | 国产精品情人露脸在线观看 | 8090成人午夜精品 | 久久国产精品国产精品 | 高清国产一级毛片国语 | 精品国产九九 | 丝袜 亚洲 另类 欧美 变态 | 国产高清一级毛片在线人 | 尤物蜜芽福利国产污在线观看 | 欧美三级在线免费观看 | 亚洲综合精品香蕉久久网 | 亚洲精品一区国产二区 | 不卡中文一二三区 | 欧美伦禁片在线播放 | 人人爽久久涩噜噜噜蜜桃 | 欧洲无线区一二区 | 日本a及毛片免费视频 | 2021久久精品国产99国产精品 | 久久线看观看精品香蕉国产 | 免费国产成高清人在线视频 | 国内精品第一页 | 一级免费黄色大片 | 日韩一区二区三区免费 | 一区视频免费观看 | 美女久久久久久久久久久 | 精品一区二区三区免费毛片爱 | 亚洲欧美第一 | 做a视频大全 | 亚洲免费播放 | 性激烈的欧美暴力三级视频 | 国产成人影院 | 欧美日本一道本 | 国产视频精品免费 | 国产一级毛片外aaaa | 成年女人毛片免费观看不卡 |